HI-Bio: A Biogen Company Employee Directory
Biotechnology ResearchCalifornia, United States11-50 Employees
HI-Bio, a clinical-stage biotechnology company, focuses on developing targeted therapies for immune-mediated diseases. Based in South San Francisco, California, it pursues precision approaches intended to benefit patients with severe IMDs. The company has been acquired by Biogen, and its dedicated updates are now managed under Biogen's umbrella, with HI-Bio's standalone page no longer maintained. In January 2024, the company announced the appointment of Chris Dimitropoulos to its Board of Directors. Dimitropoulos is the Managing Director of Healthcare Investments at Alpha Wave Global.